These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38562760)

  • 1. Greater Role of Cognitive Impairment Over Fatigue in Post-COVID-19 Quality of Life: A Post-Hoc Analysis of a Randomized Controlled Trial.
    Kwan ATH; Lakhani M; Le GH; Singh G; Teopiz KM; Guo Z; Ceban F; Dhaliwal KK; Badulescu S; Ho R; Rhee TG; Cao B; d'Andrea G; McIntyre RS
    medRxiv; 2024 Mar; ():. PubMed ID: 38562760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial.
    McIntyre RS; Phan L; Kwan ATH; Mansur RB; Rosenblat JD; Guo Z; Le GH; Lui LMW; Teopiz KM; Ceban F; Lee Y; Bailey J; Ramachandra R; Di Vincenzo J; Badulescu S; Gill H; Drzadzewski P; Subramaniapillai M
    Brain; 2024 Mar; 147(3):849-857. PubMed ID: 37936330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysis.
    Teopiz KM; Kwan ATH; Le GH; Guo Z; Badulescu S; Ceban F; Meshkat S; Di Vincenzo JD; d'Andrea G; Cao B; Ho R; Rhee TG; Dev DA; Phan L; Subramaniapillai M; Mansur RB; Rosenblat JD; McIntyre RS
    Curr Med Res Opin; 2024 Jul; 40(7):1203-1209. PubMed ID: 38860901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of vortioxetine on psychosocial functioning moderated by symptoms of fatigue in post-COVID-19 condition: a secondary analysis.
    Badulescu S; Le GH; Wong S; Kwan ATH; Guo Z; Teopiz KM; Phan L; Subramaniapillai M; Rosenblat JD; Mansur RB; McIntyre RS
    Neurol Sci; 2024 Apr; 45(4):1335-1342. PubMed ID: 38321333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine.
    Kwan ATH; Le GH; Guo Z; Ceban F; Teopiz KM; Rhee TG; Ho R; Di Vincenzo JD; Badulescu S; Meshkat S; Cao B; Rosenblat JD; Dev DA; Phan L; Subramaniapillai M; McIntyre RS
    Ann Gen Psychiatry; 2024 Feb; 23(1):10. PubMed ID: 38424537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective and Objective Measures of Cognitive Function are Correlated in Persons with Post-COVID-19 Condition: A Secondary Analysis of a Randomized Controlled Trial.
    Kwan ATH; Lakhani M; Le GH; Singh G; Teopiz KM; Ceban F; Nijjar CS; Meshkat S; Badulescu S; Ho R; Rhee TG; Vincenzo JDD; Gill H; McIntyre RS
    medRxiv; 2024 Mar; ():. PubMed ID: 38562707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine.
    Kwan ATH; Guo Z; Ceban F; Le GH; Wong S; Teopiz KM; Rhee TG; Ho R; Di Vincenzo JD; Badulescu S; Meshkat S; Cao B; Rosenblat JD; d'Andrea G; Dev DA; Phan L; Subramaniapillai M; McIntyre RS
    Adv Ther; 2024 May; 41(5):1983-1994. PubMed ID: 38520501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Baseline Anxiety on Well-being in People with Post-COVID-19 Condition: A Secondary Analysis.
    Kleine N; Kwan ATH; Le GH; Guo Z; Phan L; Subramaniapillai M; McIntyre RS
    CNS Spectr; 2024 Apr; 29(2):150-154. PubMed ID: 38453677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of elevated body mass index (BMI) on cognitive functioning and inflammation in persons with post-COVID-19 condition: a secondary analysis.
    Le GH; Kwan ATH; Guo Z; Wong S; Badulescu S; Gill H; Teopiz KM; Meshkat S; Ceban F; Phan L; Subramaniapillai M; Di Vincenzo JD; Rosenblat JD; Mansur RB; d'Andrea G; Ho R; Rhee TG; McIntyre RS
    Acta Neuropsychiatr; 2024 Apr; ():1-7. PubMed ID: 38605630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between anhedonia and psychosocial functioning in post-COVID-19 condition: a
    Liao S; Teopiz KM; Kwan ATH; Le GH; Wong S; Ballum H; Rhee TG; Badulescu S; Cao B; Guo Z; Meshkat S; Phan L; Subramaniapillai M; Ho R; McIntyre RS
    Curr Med Res Opin; 2024 Jul; ():1-5. PubMed ID: 38954402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Elevated Body Mass Index (BMI) on Hedonic Tone in Persons with Post-COVID-19 Condition: A Secondary Analysis.
    Le GH; Kwan ATH; Wong S; Guo Z; Teopiz KM; Badulescu S; Meshkat S; d'Andrea G; Ho R; Rhee TG; Cao B; Phan L; Rosenblat JD; Mansur RB; Subramaniapillai M; McIntyre RS
    Adv Ther; 2024 Feb; 41(2):686-695. PubMed ID: 38114867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-OSU6162 in the treatment of fatigue and other sequelae after aneurysmal subarachnoid hemorrhage: a double-blind, randomized, placebo-controlled study.
    Western E; Nordenmark TH; Sorteberg W; Sorteberg A; Karic T; Sorteberg A
    J Neurosurg; 2022 Jun; 136(6):1705-1715. PubMed ID: 34715650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of vortioxetine on depressive symptoms moderated by symptoms of anxiety in persons with post-COVID-19 condition: A secondary analysis.
    Le GH; Kwan ATH; Guo Z; Teopiz KM; Wong S; Meshkat S; d'Andrea G; Ho R; Rhee TG; Cao B; Badulescu S; Phan L; Rosenblat JD; Mansur RB; Subramaniapillai M; McIntyre RS
    Psychiatry Res; 2024 Jun; 339():116068. PubMed ID: 38954891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise interventions on health-related quality of life for people with cancer during active treatment.
    Mishra SI; Scherer RW; Snyder C; Geigle PM; Berlanstein DR; Topaloglu O
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD008465. PubMed ID: 22895974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise therapy for chronic fatigue syndrome.
    Larun L; Brurberg KG; Odgaard-Jensen J; Price JR
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD003200. PubMed ID: 28444695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise therapy for chronic fatigue syndrome.
    Larun L; Brurberg KG; Odgaard-Jensen J; Price JR
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD003200. PubMed ID: 27995604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise therapy for chronic fatigue syndrome.
    Larun L; Brurberg KG; Odgaard-Jensen J; Price JR
    Cochrane Database Syst Rev; 2016 Jun; (6):CD003200. PubMed ID: 27339435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise therapy for chronic fatigue syndrome.
    Larun L; Brurberg KG; Odgaard-Jensen J; Price JR
    Cochrane Database Syst Rev; 2016 Feb; 2():CD003200. PubMed ID: 26852189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.